Advertisement

Risk of HBV reactivation in patients with B-cell lymphomas receiving obinutuzumab or rituximab immunochemotherapy

Shigeru Kusumoto, Luca Arcaini, Xiaonan Hong, Jie Jin, Won Seog Kim, Yok Lam Kwong, Marion G. Peters, Yasuhito Tanaka, Andrew D. Zelenetz, Hiroshi Kuriki, Günter Fingerle-Rowson, Tina Nielsen, Eisuke Ueda, Hanna Piper-Lepoutre, Gila Sellam and Kensei Tobinai

Article Information

PubMed 

Print ISSN 
Online ISSN 
History 
  • Submitted April 27, 2018
  • Accepted October 2, 2018
  • Published online October 19, 2018.

Article Versions


Contributors 
  • Shigeru Kusumoto, 1 Nagoya City University Graduate School of Medical Science, Nagoya, Japan;
  • Luca Arcaini, 2 Division of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo and Department of Molecular Medicine, University of Pavia, Pavia, Italy;
  • Xiaonan Hong, 3 Fudan University Shanghai Cancer Center, Shanghai, China;
  • Jie Jin, 4 The First Affiliated Hospital, Zhejiang University College of Medicine, Hangzhou, China;
  • Won Seog Kim, 5 Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of;
  • Yok Lam Kwong, 6 Queen Mary Hospital, Hong Kong, China;
  • Marion G. Peters, 7 University of California San Francisco, San Francisco, CA, United States;
  • Yasuhito Tanaka, 1 Nagoya City University Graduate School of Medical Science, Nagoya, Japan;
  • Andrew D. Zelenetz, 8 Memorial Sloan Kettering Cancer Center and Weill Cornell Medical Center, New York, NY, United States;
  • Hiroshi Kuriki, 9 Chugai Pharmaceutical Co Ltd, Tokyo, Japan;
  • Günter Fingerle-Rowson, 10 F. Hoffmann-La Roche Ltd, Basel, Switzerland;
  • Tina Nielsen, 10 F. Hoffmann-La Roche Ltd, Basel, Switzerland;
  • Eisuke Ueda, 9 Chugai Pharmaceutical Co Ltd, Tokyo, Japan;
  • Hanna Piper-Lepoutre, 10 F. Hoffmann-La Roche Ltd, Basel, Switzerland;
  • Gila Sellam, 10 F. Hoffmann-La Roche Ltd, Basel, Switzerland;
  • Kensei Tobinai, 11 National Cancer Center Hospital, Tokyo, Japan

Altmetric.com Statistics

The Altmetric score is a weighted count of online attention designed to reflect the volume and reach of online engagement surrounding an individual research output